Compagnie Lombard Odier SCmA’s Ekso Bionics EKSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.48K | Sell |
1,666
-1
| -0.1% | -$3 | ﹤0.01% | 398 |
|
|
2025
Q1 | $10.1K | Hold |
1,667
| – | – | ﹤0.01% | 425 |
|
|
2024
Q4 | $15.3K | Hold |
1,667
| – | – | ﹤0.01% | 399 |
|
|
2024
Q3 | $29K | Hold |
1,667
| – | – | ﹤0.01% | 372 |
|
|
2024
Q2 | $26.4K | Hold |
1,667
| – | – | ﹤0.01% | 370 |
|
|
2024
Q1 | $34K | Hold |
1,667
| – | – | ﹤0.01% | 381 |
|
|
2023
Q4 | $62.5K | Hold |
1,667
| – | – | ﹤0.01% | 391 |
|
|
2023
Q3 | $18.3K | Hold |
1,667
| – | – | ﹤0.01% | 492 |
|
|
2023
Q2 | $35.8K | Hold |
1,667
| – | – | ﹤0.01% | 443 |
|
|
2023
Q1 | $41.3K | Hold |
1,667
| – | – | ﹤0.01% | 462 |
|
|
2022
Q4 | $30K | Hold |
1,667
| – | – | ﹤0.01% | 540 |
|
|
2022
Q3 | $39K | Hold |
1,667
| – | – | ﹤0.01% | 480 |
|
|
2022
Q2 | $41K | Hold |
1,667
| – | – | ﹤0.01% | 461 |
|
|
2022
Q1 | $72K | Hold |
1,667
| – | – | ﹤0.01% | 407 |
|
|
2021
Q4 | $66K | Sell |
1,667
-666
| -29% | -$26.4K | ﹤0.01% | 480 |
|
|
2021
Q3 | $162K | Hold |
2,333
| – | – | ﹤0.01% | 375 |
|
|
2021
Q2 | $193K | Hold |
2,333
| – | – | ﹤0.01% | 343 |
|
|
2021
Q1 | $216K | Buy |
+2,333
| New | +$216K | ﹤0.01% | 376 |
|